MD596Y - Method for treating the chronic viral hepatitis C - Google Patents

Method for treating the chronic viral hepatitis C Download PDF

Info

Publication number
MD596Y
MD596Y MDS20120138A MDS20120138A MD596Y MD 596 Y MD596 Y MD 596Y MD S20120138 A MDS20120138 A MD S20120138A MD S20120138 A MDS20120138 A MD S20120138A MD 596 Y MD596 Y MD 596Y
Authority
MD
Moldova
Prior art keywords
bgr
glucopyranosyl
viral hepatitis
day
chronic viral
Prior art date
Application number
MDS20120138A
Other languages
Moldavian (mo)
Romanian (ro)
Inventor
Constantin Spanu
Tatiana Raba
Igor Spihnu
Vladimir Guriev
Octavian Sajen
Igor Spanu
Original Assignee
Ct Nat De Sanatate Publica Al Ministerului Sanatatii Al Republicii Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Nat De Sanatate Publica Al Ministerului Sanatatii Al Republicii Moldova filed Critical Ct Nat De Sanatate Publica Al Ministerului Sanatatii Al Republicii Moldova
Priority to MDS20120138A priority Critical patent/MD596Z/en
Publication of MD596Y publication Critical patent/MD596Y/en
Publication of MD596Z publication Critical patent/MD596Z/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, in particular to hepatology, and can be used for the treatment of chronic viral hepatitis C.According to the invention, the claimed method consists in that it is administered the basic therapy and additionally, is concomitantly administered per os 5α-furostan-3&bgr;,22,26-triol-3-¢O-&bgr;-D-glucopyranosyl(1→2)-&bgr;-D-glucopyranosyl(1→4)-&bgr;-D-galactopyranosyl]-26-O-&bgr;-D-glucopyranosyl, twice a day, and 3-O-¢&bgr;-D-glucopyranosyl(1→2)]-¢&bgr;-D-glucopyranosyl(1→3)]-¢&bgr;-D-glucopyranosyl(1→4)-&bgr;-D-galactopyranosyl¢(25R)-5α-furostan-2α, 3&bgr;, 22α, 26-tetraol]-26-O-&bgr;-D-glucopyranosyl, once a day, both remedies are administered in a dose of 50 mg, beginning with the first day of clinical manifestations, 30 minutes before meal, during 3 months.
MDS20120138A 2012-10-09 2012-10-09 Method for treating chronic viral hepatitis C in children MD596Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20120138A MD596Z (en) 2012-10-09 2012-10-09 Method for treating chronic viral hepatitis C in children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20120138A MD596Z (en) 2012-10-09 2012-10-09 Method for treating chronic viral hepatitis C in children

Publications (2)

Publication Number Publication Date
MD596Y true MD596Y (en) 2013-02-28
MD596Z MD596Z (en) 2013-09-30

Family

ID=47831233

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20120138A MD596Z (en) 2012-10-09 2012-10-09 Method for treating chronic viral hepatitis C in children

Country Status (1)

Country Link
MD (1) MD596Z (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD667Z (en) * 2013-03-20 2014-03-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for treatment of infectious mononucleosis in children

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2046139C1 (en) * 1993-02-02 1995-10-20 Институт генетики АН Республики Молдова Inhibitor of rotaviruses
WO1995003056A1 (en) * 1993-07-19 1995-02-02 Tokyo Tanabe Company Limited Hepatitis c virus proliferation inhibitor
MD1875G2 (en) * 1999-11-01 2002-09-30 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the acute viral hepatitis B
MD2203G2 (en) * 2001-04-11 2004-01-31 Институт Генетики И Физиологии Растений Академии Наук Молдовы Process for treatment of pepper seeds
MD2549G2 (en) * 2003-07-18 2005-08-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the chronic viral hepatitis C
MD3121G2 (en) * 2005-09-15 2007-03-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of viral hepatitis B prophylaxis
MD3477G2 (en) * 2007-03-21 2008-08-31 Николае БОДРУГ Method of treating the chronic viral hepatitis C
TWI476190B (en) * 2009-03-30 2015-03-11 必治妥美雅史谷比公司 Hepatitis c virus inhibitors
MD177Z (en) * 2010-01-15 2010-11-30 Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы Process for the treatment of apricot
  • 2012

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD667Z (en) * 2013-03-20 2014-03-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for treatment of infectious mononucleosis in children

Also Published As

Publication number Publication date
MD596Z (en) 2013-09-30

Similar Documents

Publication Publication Date Title
PH12018500097A1 (en) Combination of pd-1 antagonist with an egfr inhibitor
EA201690738A1 (en) DRY POWDER INHALER
MX2014004548A (en) Methods of treating pediatric patients using dexmedetomidine.
MX2015013355A (en) THERAPY INVOLVING ANTIBODIES AGAINST CLAUDINE 18.2 FOR THE CANCER TREATMENT.
JO3784B1 (en) Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
NZ723271A (en) Fused imidazole derivatives useful as ido inhibitors
MX2020008258A (en) Pediatric niraparib formulations and pediatric treatment methods.
MX2014001050A (en) Treatment of multiple sclerosis with combination of laquinimod and glatiramer acetate.
MX2017006938A (en) Combination therapy for treatment of cancer.
MX359770B (en) Combination therapy of a mek inhibitor and igf1r inhibitor.
AR104771A1 (en) DRY POWDER INHALER
JOP20190019A1 (en) Pharmaceutical Formula for Treatment of Growth Hormone Deficiency Contains Human Growth Hormone (hGH) Fusion Protein
MX2015009546A (en) Increased dosage of efavirenz for the treatment of cancer.
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
MX2022000394A (en) Therapeutic combinations of orally administered paclitaxel and a p-gp inhibitor for the treatment of cancer.
MD596Y (en) Method for treating the chronic viral hepatitis C
MY180772A (en) Novel therapeutic mirtazapine combinations for use in pain disorders
JOP20170044B1 (en) Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
TW201613599A (en) Use of composition for manufacture of medicament for suppressing androgen receptor related function and treatment of androgen receptor related disease
MX2019011749A (en) Reducing beta-catenin expression to potentiate immunotherapy.
MX393290B (en) Composition for the treatment of osteoarthritis
MD3987C2 (en) Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
RU2016143243A (en) ANTITUMEN AGENT CONTAINING A TAXANI COMPOUND AND ANTITUMEN EFFECT AMPLIFIER
Lin Hypertension, diarrhoea and hand-foot syndrome: 4 case reports
Chen Lupus pernio-like eruption: case report

Legal Events

Date Code Title Description
FG9Y Short term patent issued
MK4Y Short term patent expired